Swedish medtech company IRRAS has raised SKr217m (US$22.3m) in a fully underwritten rights issue to help commercialise its products. Disappointingly, only 56.8% of the offered shares, were subscribed for by…
Swedish medtech company IRRAS has raised SKr217m (US$22.3m) in a fully underwritten rights issue to help commercialise its products. Disappointingly, only 56.8% of the offered shares, were subscribed for by…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference